Quebec’s IVF restrictions: Economics or ethics?
By MARINA ADSHADE,
The Globe and Mail
| 12. 12. 2014
Last week, Quebec Health Minister Gaétan Barrette tabled a bill
that, if passed, will prohibit women over the age of 42 from having
access to in vitro fertilization (IVF). While the purpose of the bill,
on the surface at least, is to lessen financial strain on the health
care system, this particular section of the bill will achieve a
different outcome; it will reduce the number of births to Quebec women
who rely on the use of donated eggs to conceive.
More Related to this Story
Quebec started providing medicare for
assistive reproductive technologies (ART) in 2010 in the hope of
achieving three objectives: reduce health care costs resulting from
multiple births; enable infertile couples to have children; and increase
the number of births in the province by between 1,000 and 1,500 per
year.
Despite claims that the program
has been widely abused, the number of births to Quebec woman has only
fallen since...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Nicky Hudson, The Conversation | 08.12.2025
